Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology
Diagnostic Performance of F-18 Flurpiridaz in Women: A Sub-study of the Aurora Phase 3 Trial.
Stephen J Horgan, Gary V Heller, Jamshid Maddahi, Timothy M Bateman, Jeroen J Bax, Rob S B Beanlands, Daniel S Berman, Ernest V Garcia, Edward Somer, Nagara Tamaki, David Thompson, James E Udelson
Published: 202610.1016/j.nuclcard.2026.102640
Abstract
BACKGROUND: A recent phase 3 study of the PET perfusion tracer F-18 flurpiridaz (flurpiridaz) met the primary efficacy endpoint for the detection of CAD, demonstrating statistically higher sensitivity, non-inferior specificity compared to Tc-99m-tetr…
Preview only. Read the full abstract at the source